Hypertriglyceridemia omega-3 fatty acids: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Hypertriglyceridemia}} {{CMG}}; '''Associate Editor(s)-In-Chief:''' Priyamvada Singh, M.B.B.S. [mailto:psingh@perfuse.org] ==Overview== Treatment of hype...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Hypertriglyceridemia}} | {{Hypertriglyceridemia}} | ||
'''For full Omega-3 fatty acid drug info click [[Omega-3 fatty acid|here]]''' | |||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org] | ||
| Line 10: | Line 12: | ||
* Decreased hepatic [[lipogenesis]] | * Decreased hepatic [[lipogenesis]] | ||
* Increased plasma [[lipoprotein lipase]] activity. | * Increased plasma [[lipoprotein lipase]] activity. | ||
* Increased hepatic mitochondrial and peroxisomal beta-oxidation | * Increased hepatic mitochondrial and peroxisomal [[beta-oxidation]] | ||
* Inhibition of acyl CoA:1,2-diacylglycerol acyltransferase enzyme | * Inhibition of acyl CoA:1,2-[[diacylglycerol acyltransferase]] enzyme | ||
* Omega-3 fatty | * [[Omega-3 fatty acid]]s component EPA and DHA are poor enzyme substrates for triglyceride synthesis in the liver | ||
* EPA and DHA | * EPA and DHA inhibits esterification of other fatty acids. | ||
==References== | ==References== | ||
Revision as of 01:40, 3 October 2011
For full Omega-3 fatty acid drug info click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Treatment of hypertriglyceridemia is by restriction of carbohydrates and fat in the diet, as well as with niacin, fibrates and statins (three classes of drugs). Increased fish oil intake may substantially lower an individual's triglycerides.[1][2][3].
Omega-3 fatty acids
Mechanism of benefit
- Decreased hepatic lipogenesis
- Increased plasma lipoprotein lipase activity.
- Increased hepatic mitochondrial and peroxisomal beta-oxidation
- Inhibition of acyl CoA:1,2-diacylglycerol acyltransferase enzyme
- Omega-3 fatty acids component EPA and DHA are poor enzyme substrates for triglyceride synthesis in the liver
- EPA and DHA inhibits esterification of other fatty acids.
References
- ↑ "Lipids Online Slides: hypertriglyceridemia, ICAM-1, fish oil, E-selectin".
- ↑ Terres W, Beil U, Reimann B, Tiede S, Bleifeld W (1991). "[Low-dose fish oil in primary hypertriglyceridemia. A randomized placebo-controlled study]". Zeitschrift für Kardiologie (in German). 80 (1): 20–4. PMID 2035283.
- ↑ "Fish oils in hypertriglyceridemia - Fish Oils Revisited Nutrition Research Newsletter - Find Articles".